This helps it stay in place, even during daily activities
This claim builds on research from Harvard published in July 2024, which found a significantly increased risk of NAION among semaglutide users, followed by additional studies in January 2025 and warnings from the Danish Medicines Agency
GLP-1 medications safe to continue before surgery in patients with diabetes and obesity owenhaskins Jun 5, 2024 3 min read There are only mild differences in gastric emptying among patients taking glucagon-like peptide-1 (GLP-1) receptor agonist medications for type 2 diabetes and weight loss, according to a meta-analysis and review of 15 randomised studies by researchers from Brigham and Womens Hospital
Just when you thought you knew what to expect with GLP-1s, new research emerges that gives you pause
Step 6: Ongoing treatment and monthly check-ins
The case is part of the Ozempic lawsuit currently pending in federal court in Pennsylvania